-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Idoxuridine
Category | Herpes simplex Virus (HSV) |
CAS | 54-42-2 |
Description | 5-Iodo-2'-deoxyuridine is a nucleoside analog that can be incorporated into viral DNA replication to treat herpes simplex keratitis. |
Product Information
Synonyms | 5-Iodo-2'-deoxyuridine; IDU; 2'-Deoxy-5-iodouridine; 5-Iodo-2'-deoxy-D-uridine; 1-(2-Deoxy-β-D-ribofuranosyl)-5-iodouracil; IUdR; Dendrid; Emanil; NSC 39661; Ophthalmadine; Herpesil; Herpidu; Herplex; Stoxil; Stoxip; Synmiol; Virudox |
IUPAC Name | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione |
Molecular Weight | 354.10 |
Molecular Formula | C9H11IN2O5 |
Canonical SMILES | C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O |
InChI | InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 |
InChIKey | XQFRJNBWHJMXHO-RRKCRQDMSA-N |
Melting Point | >160°C (dec.) |
Purity | ≥98% by HPLC |
Density | 2.14±0.1 g/cm3 |
Solubility | Soluble in DMSO (Slightly, Sonicated), Methanol (Slightly, Heated), Water (Slightly, Heated |
Appearance | White Crystalline Powder |
Application | 5-Iodo-2'-deoxyuridine is a nucleoside analog treat herpes simplex keratitis. |
Storage | Store at -20°C |
Complexity | 386 |
Exact Mass | 353.97127 |
Index Of Refraction | 1.715 |
In Vitro | Idoxuridine (2-10 μM, 72 hours) has the IC50 value of 4.3 μM of antiviral. |
In Vivo | Idoxuridine (intraperitoneal injection, 50-200 mg/kg, 3 times, 3 hours interval) can stimulate the production of hemolysin plaque-forming cells (HPFC) to sheep red blood cells (SRBC) in C3HeB/FeJ female and male mice and A/J male mice. |
PSA | 104.55000 |
Target | Phosphatase; Orthopoxvirus |
XLogP3-AA | -1 |